End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.39 CNY | +1.80% | +6.94% | -25.00% |
Jan. 31 | Hainan Haiyao’s Antibiotic Passes Generic Evaluation | MT |
2023 | Hainan Haiyao's Unit Gets Nod to Become Marketing License Holder of Shuangshen Huoxue Tongluo Granules | MT |
Sales 2021 | 2.06B 284M | Sales 2022 | 1.78B 246M | Capitalization | 5.54B 765M |
---|---|---|---|---|---|
Net income 2021 | -1.56B -215M | Net income 2022 | 10M 1.38M | EV / Sales 2021 | 4.67 x |
Net Debt 2021 | 2.81B 387M | Net Debt 2022 | 3.08B 425M | EV / Sales 2022 | 4.84 x |
P/E ratio 2021 |
-4.38
x | P/E ratio 2022 |
527
x | Employees | 2,247 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 58.32% |
1 day | +1.80% | ||
1 week | +6.94% | ||
Current month | -8.38% | ||
1 month | -12.40% | ||
3 months | -13.30% | ||
6 months | -20.61% | ||
Current year | -25.00% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Hong Wang
CEO | Chief Executive Officer | 55 | 22-04-07 |
Rong Yi Xu
DFI | Director of Finance/CFO | 53 | 21-06-28 |
Jian Min Zhang
CTO | Chief Tech/Sci/R&D Officer | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xi Cheng Liu
BRD | Director/Board Member | 62 | 05-04-15 |
Duo Jia Feng
BRD | Director/Board Member | 66 | - |
Jun Hong Wang
CEO | Chief Executive Officer | 55 | 22-04-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 3.39 | +1.80% | 6,904,800 |
24-04-22 | 3.33 | +0.60% | 6,208,200 |
24-04-19 | 3.31 | -0.60% | 6,006,491 |
24-04-18 | 3.33 | -2.35% | 9,860,179 |
24-04-17 | 3.41 | +7.57% | 12,152,060 |
End-of-day quote Shenzhen S.E., April 22, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-25.00% | 607M | |
+27.92% | 672B | |
+27.68% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+6.30% | 217B | |
+4.80% | 199B | |
-6.05% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- 000566 Stock